Skip to Main Content
Prescriber Insights Combined Logo
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First-Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
New Podcast CE/CME Alert: "Meds for Alzheimer Dementia" is now available! Listen for FREE now. Subscribers can earn CE credits just for listening and passing a short quiz.
  1. Home
  2. Browse
  3. Renal & Urology
  4. Drug Use in Renal Insufficiency
  5. Cardiology

Cardiology

  • Benign Prostatic Hypertrophy (15)
  • Cystitis (1)
  • Drug-Induced Nephrotoxicity (103)
  • Drug Use in Renal Insufficiency (212)
    • Bone/Joint and Rheumatology (19)
    • Cardiology (83)
      • Aldosterone Antagonists (20)
      • Alpha-1 Blockers (3)
      • Anticoagulants/Antiplatelets (38)
      • Beta-Blockers (26)
      • Calcium Channel Blockers (11)
      • Cholesterol Lowering Drugs (13)
      • Direct Renin Inhibitors (7)
    • Endocrinology (45)
    • Gastroenterology (21)
    • Hematology/Oncology (14)
    • Infectious Diseases (48)
    • Men's Health (1)
    • Neurology/Psychiatry (14)
    • Women's Health (3)
  • Hyperkalemia (12)
  • Hypernatremia (2)
  • Hypokalemia (2)
  • Hyponatremia (6)
  • Incontinence (6)
  • Kidney Cancer (1)
  • Kidney Disease (38)
  • Kidney Stones (15)
  • Nephrology (56)
  • Overactive Bladder (24)
  • Resources (60)
  • Urinary Retention (8)
  • UTIs (63)
  • Urine Drug Testing (13)
61 - 75 of 83 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Patient Education: Heart Failure Meds and More October 2013
Chart: Target Doses of Post-MI Medications October 2013
Article: boxed warning about stopping Pradaxa (dabigatran), Xarelto (rivaroxaban), or Eliquis (apixaban) in atrial fib patients July 2013
PL Voices: Adherence with the New Oral Anticoagulants July 2013
Patient Education: Why It’s Important to Take Your Blood Thinning Meds June 2013
Article: Does it ever make sense to COMBINE an ACEI with an ARB...or aliskiren (Tekturna) with an ACEI or ARB March 2013
PL Voices: Combining ACEIs, ARBs, or Aliskiren (Tekturna) March 2013
Article: approval of Eliquis (ELL-eh-kwiss, apixaban) will intensify the marketing war among the NEW oral anticoagulants February 2013
PL Voices: Comparing the New Oral Anticoagulants February 2013
PL Voices: Managing Bleeding with Pradaxa (dabigatran) or Xarelto (rivaroxaban) December 2012
Commentary: Update on the Risk for Serious Bleeding Events with Pradaxa December 2012
Article: more about bleeding with Pradaxa (dabigatran) December 2012
Article: NEW Beers criteria for potentially inappropriate meds in patients 65 and over June 2012
PL Voices: Potentially Inappropriate Prescribing in the Elderly June 2012
Commentary: New Drug: Xarelto (Rivaroxaban) August 2011
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved